Japanese researchers say mice lacking vitamin C age four times faster than normal mice, suggesting the vitamin might help slow aging in humans.
The scientists from the Tokyo Medical and Dental University and the Tokyo Metropolitan Institute of Gerontology analyzed a specific protein that decreases as aging proceeds and found it was the same as an enzyme that synthesizes vitamin C, the Mainichi news service reported.
After six months of observation, researchers said normal mice without the protein were all still alive, but half of the ones lacking the protein had died of old age.
Subsequently the researchers determined the level of vitamin C in the mice without the protein was one-tenth that of the level in normal mice.
Since humans are unable to produce vitamin C in their body even if they have the protein, the results of the experiment do not directly indicate vitamin C is effective in preventing aging in humans. But researchers told Mainichi mice that do not have the protein might be utilized in research into human aging.
The study is reported online in the electronic edition of the Proceedings of the National Academy of Sciences.
Copyright 2006 by United Press International
Related stories:
Study finds B-vitamin deficiency may cause vascular cognitive impairment
A deficiency of B-vitamins may cause vascular cognitive impairment, according to a new study. Researchers at the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University used an experimental model to examine the metabolic, cognitive, and microvascular effects of dietary B-vitamin deficiency. Their findings appear in the August 26, 2008 issue of
Proceedings of the National Academy of Sciences (PNAS).
Researchers unravel key mechanism of cellular damage in aging and disease
Researchers have taken a first snapshot of how a class of highly reactive molecules inflicts cellular damage as part of aging, heart disease, stroke, cancer, diabetes, kidney disease and Alzheimer's disease to name a few. According to a study published today in the journal
Cell, researchers have discovered a tool that can monitor related damage and determine the degree to which antioxidant drugs effectively combat disease.
Low vitamin D levels associated with an increased risk of peripheral arterial disease
Low levels of vitamin D may be associated with an increased risk for peripheral arterial disease (PAD), researchers reported at the American Heart Association’s Arteriosclerosis, Thrombosis and Vascular Biology Annual Conference 2008.
How humans make up for an 'inborn' vitamin C deficiency
A new study appears to explain how humans, along with other higher primates, guinea pigs and fruit bats, get by with what some have called an “inborn metabolic error”: an inability to produce vitamin C from glucose.
Researchers unlock mysteries of vitamin A metabolism during embryonic development
Researchers at Rutgers have unlocked some of the mysteries of how the developing embryo reacts to fluctuations in the amount of vitamin A present in the maternal blood stream. Their results are presented in the February 28 issue of the
Journal of Biological Chemistry.
Impact of elevated homocysteine levels on vision under study
Homocysteine, an amino acid believed to contribute to heart attack, stroke and dementia, likely also is a player in retinal damage and vision loss, researchers say.
Researchers reveal repressor protein blocks neural stem cell development
A protein known to repress gene transcription at the molecular level in a variety of processes also blocks embryonic neural stem cells from differentiating into neurons, according to a study by University of California, San Diego and Howard Hughes Medical Institute (HHMI) researchers published online October 10 in
Nature.
How vitamin C stops the big 'C'
Nearly 30 years after Nobel laureate Linus Pauling famously and controversially suggested that vitamin C supplements can prevent cancer, a team of Johns Hopkins scientists have shown that in mice at least, vitamin C - and potentially other antioxidants - can indeed inhibit the growth of some tumors -- just not in the manner suggested by years of investigation.